(MLKN) MillerKnoll - Overview
Stock: Seating, Furniture, Textiles, Storage, Furnishings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.05% |
| Yield on Cost 5y | 2.82% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 92.7% |
| Payout Ratio | 39.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.3% |
| Relative Tail Risk | -14.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -8.64 |
| Character TTM | |
|---|---|
| Beta | 1.096 |
| Beta Downside | 0.937 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.31% |
| CAGR/Max DD | 0.06 |
Description: MLKN MillerKnoll January 16, 2026
MillerKnoll Inc. (NASDAQ: MLKN) designs, manufactures, and distributes a broad portfolio of interior furnishings-including seating, casegoods, textiles, and specialty solutions-for contract, retail, and residential markets worldwide. The firm operates through three reporting segments: North America Contract, International Contract, and Global Retail.
The company’s product slate is sold under a suite of legacy and contemporary brands such as Herman Miller, Knoll, Design Within Reach, HAY, and Muuto, among others. Distribution is executed via independent contract dealers, direct-to-client sales teams, owned and partner retailers, catalog channels, and expanding e-commerce platforms.
Key recent performance indicators (FY 2023) show revenue of approximately $5.3 billion, an operating margin near 12 percent, and a net income of $450 million, reflecting resilience despite a softening office-furniture market. The business is sensitive to macro-drivers like corporate office-space utilization trends, inflationary pressure on raw-material costs, and ESG-focused procurement that favors sustainably-produced furniture.
Sector-level data indicate that U.S. office-furniture shipments are expected to grow 3-4 % annually through 2026, while demand for flexible-workplace solutions is accelerating in Europe and Asia-Pacific-areas where MillerKnoll’s International Contract segment is expanding its footprint.
For a deeper quantitative dive, ValueRay’s platform offers granular financial metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -25.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.49 > 1.0 |
| NWC/Revenue: 11.92% < 20% (prev 11.75%; Δ 0.17% < -1%) |
| CFO/TA 0.05 > 3% & CFO 206.9m > Net Income -25.4m |
| Net Debt (1.64b) to EBITDA (83.3m): 19.70 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (69.0m) vs 12m ago -1.46% < -2% |
| Gross Margin: 38.67% > 18% (prev 0.39%; Δ 3828 % > 0.5%) |
| Asset Turnover: 93.91% > 50% (prev 89.02%; Δ 4.88% > 0%) |
| Interest Coverage Ratio: 0.18 > 6 (EBITDA TTM 83.3m / Interest Expense TTM 73.2m) |
Altman Z'' 1.58
| A: 0.11 (Total Current Assets 1.12b - Total Current Liabilities 671.7m) / Total Assets 3.95b |
| B: 0.17 (Retained Earnings 684.2m / Total Assets 3.95b) |
| C: 0.00 (EBIT TTM 13.1m / Avg Total Assets 3.99b) |
| D: 0.24 (Book Value of Equity 615.7m / Total Liabilities 2.59b) |
| Altman-Z'' Score: 1.58 = BB |
Beneish M -3.13
| DSRI: 0.93 (Receivables 361.9m/371.5m, Revenue 3.75b/3.59b) |
| GMI: 1.01 (GM 38.67% / 39.04%) |
| AQI: 0.96 (AQ_t 0.49 / AQ_t-1 0.51) |
| SGI: 1.04 (Revenue 3.75b / 3.59b) |
| TATA: -0.06 (NI -25.4m - CFO 206.9m) / TA 3.95b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of MLKN shares?
Over the past week, the price has changed by +12.25%, over one month by +19.64%, over three months by +56.98% and over the past year by +6.88%.
Is MLKN a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MLKN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 42% |
| Analysts Target Price | 32 | 42% |
| ValueRay Target Price | 25.7 | 14.1% |
MLKN Fundamental Data Overview February 03, 2026
P/S = 0.367
P/B = 1.0544
P/EG = 1.0358
Revenue TTM = 3.75b USD
EBIT TTM = 13.1m USD
EBITDA TTM = 83.3m USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 98.5m USD (from shortTermDebt, last quarter)
Debt = 1.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.64b USD (from netDebt column, last quarter)
Enterprise Value = 3.02b USD (1.38b + Debt 1.82b - CCE 180.4m)
Interest Coverage Ratio = 0.18 (Ebit TTM 13.1m / Interest Expense TTM 73.2m)
EV/FCF = 42.98x (Enterprise Value 3.02b / FCF TTM 70.2m)
FCF Yield = 2.33% (FCF TTM 70.2m / Enterprise Value 3.02b)
FCF Margin = 1.87% (FCF TTM 70.2m / Revenue TTM 3.75b)
Net Margin = -0.68% (Net Income TTM -25.4m / Revenue TTM 3.75b)
Gross Margin = 38.67% ((Revenue TTM 3.75b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Gross Margin QoQ = 38.97% (prev 38.52%)
Tobins Q-Ratio = 0.76 (Enterprise Value 3.02b / Total Assets 3.95b)
Interest Expense / Debt = 1.01% (Interest Expense 18.4m / Debt 1.82b)
Taxrate = 22.46% (7.30m / 32.5m)
NOPAT = 10.2m (EBIT 13.1m * (1 - 22.46%))
Current Ratio = 1.67 (Total Current Assets 1.12b / Total Current Liabilities 671.7m)
Debt / Equity = 1.34 (Debt 1.82b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 19.70 (Net Debt 1.64b / EBITDA 83.3m)
Debt / FCF = 23.38 (Net Debt 1.64b / FCF TTM 70.2m)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.64% (Net Income -25.4m / Total Assets 3.95b)
RoE = -1.96% (Net Income TTM -25.4m / Total Stockholder Equity 1.30b)
RoCE = 0.50% (EBIT 13.1m / Capital Employed (Equity 1.30b + L.T.Debt 1.32b))
RoIC = 0.39% (NOPAT 10.2m / Invested Capital 2.62b)
WACC = 4.73% (E(1.38b)/V(3.20b) * Re(9.95%) + D(1.82b)/V(3.20b) * Rd(1.01%) * (1-Tc(0.22)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.59%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈94.9m ; Y1≈62.3m ; Y5≈28.4m
Fair Price DCF = N/A (negative equity: EV 905.5m - Net Debt 1.64b = -735.9m; debt exceeds intrinsic value)
EPS Correlation: 21.08 | EPS CAGR: 12.12% | SUE: 0.13 | # QB: 0
Revenue Correlation: -62.56 | Revenue CAGR: -1.98% | SUE: 0.39 | # QB: 0
EPS current Year (2026-05-31): EPS=1.90 | Chg30d=+0.035 | Revisions Net=+2 | Growth EPS=-2.6% | Growth Revenue=+4.5%
EPS next Year (2027-05-31): EPS=2.24 | Chg30d=-0.017 | Revisions Net=+1 | Growth EPS=+17.7% | Growth Revenue=+4.5%